11.09.11
Albany, N.Y. a provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology,
Angio Dynamics Inc. has appointed Matthew Kapusta as senior vice president of Business Development, effective November 15, 2011, and Donna Haire, as senior vice president of Regulatory, Quality, Clinical and Medical Affairs, effective immediately.
They will report to President and CEO Joseph M. DeVivo, who recently joined the Albany, N.Y.-based device firm after leaving Smith & Nephew as head of their orthopedics division.
"Matt and Donna are immensely talented and seasoned executives with significant experience in the global medical device industry," said DeVivo. "We look forward to their leadership, as well as the work they will do to advance the company's growth through the expansion of our product portfolio."
According to a release issued by AngioDynamics, Kapusta, 39, has advised on more than 50 transactions valued at more than $6 billion. While most recently serving as vice president of Strategic Planning and Financial Analysis for Smith & Nephew Orthopaedics, he formed the Business Intelligence and Analytics team responsible for developing data-driven insights and understanding of business performance, such as surgeon attrition, sales force productivity and asset efficiency. Kapusta also spearheaded strategic and financial planning for Smith & Nephew's global Hips, Knees and Trauma franchises.
Prior to Smith & Nephew, Kapusta was a managing director of Healthcare Investment Banking at Collins Stewart in New York, N.Y. Also, he previously served as vice president of Healthcare Mergers and Acquisitions at Wells Fargo Securities, and had similar roles at Robertson Stephens and PaineWebber.
Haire, 42, most recently served as senior director of Quality, Regulatory and Sustainability at Philips Healthcare subsidiary Global Diagnostic X-Ray in Hamburg, Germany. Haire also was the Imaging Systems corporate director of Regulatory, Quality, Clinical and Standards for Philips Healthcare for 21 sites worldwide. Prior to Philips, Haire was director of Regulatory Affairs, Technical Communications and Compliance Engineering at Medtronic Emergency Response Systems in Redmond, Wash., leading the regulatory team in obtaining FDA market clearance for multiple products within six months. Previously she held leadership positions at Avery Dennison Medical and STERIS Corporation.
AngioDynamics provides devices for vascular access, surgery, peripheral vascular disease and oncology.
Angio Dynamics Inc. has appointed Matthew Kapusta as senior vice president of Business Development, effective November 15, 2011, and Donna Haire, as senior vice president of Regulatory, Quality, Clinical and Medical Affairs, effective immediately.
They will report to President and CEO Joseph M. DeVivo, who recently joined the Albany, N.Y.-based device firm after leaving Smith & Nephew as head of their orthopedics division.
"Matt and Donna are immensely talented and seasoned executives with significant experience in the global medical device industry," said DeVivo. "We look forward to their leadership, as well as the work they will do to advance the company's growth through the expansion of our product portfolio."
According to a release issued by AngioDynamics, Kapusta, 39, has advised on more than 50 transactions valued at more than $6 billion. While most recently serving as vice president of Strategic Planning and Financial Analysis for Smith & Nephew Orthopaedics, he formed the Business Intelligence and Analytics team responsible for developing data-driven insights and understanding of business performance, such as surgeon attrition, sales force productivity and asset efficiency. Kapusta also spearheaded strategic and financial planning for Smith & Nephew's global Hips, Knees and Trauma franchises.
Prior to Smith & Nephew, Kapusta was a managing director of Healthcare Investment Banking at Collins Stewart in New York, N.Y. Also, he previously served as vice president of Healthcare Mergers and Acquisitions at Wells Fargo Securities, and had similar roles at Robertson Stephens and PaineWebber.
Haire, 42, most recently served as senior director of Quality, Regulatory and Sustainability at Philips Healthcare subsidiary Global Diagnostic X-Ray in Hamburg, Germany. Haire also was the Imaging Systems corporate director of Regulatory, Quality, Clinical and Standards for Philips Healthcare for 21 sites worldwide. Prior to Philips, Haire was director of Regulatory Affairs, Technical Communications and Compliance Engineering at Medtronic Emergency Response Systems in Redmond, Wash., leading the regulatory team in obtaining FDA market clearance for multiple products within six months. Previously she held leadership positions at Avery Dennison Medical and STERIS Corporation.
AngioDynamics provides devices for vascular access, surgery, peripheral vascular disease and oncology.